Close Menu
Libya Update NewsLibya Update News
  • Home
  • National
  • Region & World
    • The Maghreb
    • Middle East
  • Business
    • Oil & Gas
    • Economy
    • Analysis
  • Opinion
  • Editors’ Picks
  • Health & Lifestyle
  • Sports
Facebook X (Twitter) RSS
Trending
  • Emmaus US Expands in Libya Through Pharmaceutical Distribution Partnership
  • MP Souad Al-Shalli Selected as Jury Member for the 2026 “Inspiring Woman” Award in Libya
  • Al-Brega: Gas carriers Derna and Al-Tahadi boost supplies as congestion begins to ease
  • Health Ministry announces death of girl from poisonous wild mushroom poisoning in Al-Bayda
  • Session at Benghazi Book Fair on the Marrakesh Treaty and Its Importance in Providing Access to Knowledge for People with Visual and Physical Disabilities
  • House of Representatives calls for withdrawal of instructions banning the issuance of flight permits for its members
  • Il Sole 24 Ore: 17 Italian experts in Benghazi to restore 9 historic buildings
  • Mountain Municipalities to Dbeibah: We Are Tired of Promises and Our Rights Are Not Up for Negotiation
  • About Us
  • Contact Us
Facebook X (Twitter) RSS
Libya Update NewsLibya Update News
Subscribe
Monday, 16 November 2026
  • Home
  • National
  • Region & World
    • The Maghreb
    • Middle East
  • Business
    • Oil & Gas
    • Economy
    • Analysis
  • Opinion
  • Editors’ Picks
  • Health & Lifestyle
  • Sports
Libya Update NewsLibya Update News
Home » New Drug Shows Promising Results in Treating Patients with Advanced Pancreatic Cancer

New Drug Shows Promising Results in Treating Patients with Advanced Pancreatic Cancer

Wednesday, June 3, 2026 Health & Lifestyle 2 Mins Read
New Drug Shows Promising Results in Treating Patients with Advanced Pancreatic Cancer

Chicago – Results from an international clinical trial suggest that a new drug, daraxxonrasib, could be a promising step forward in treating advanced pancreatic cancer. The drug was found to double the median survival period compared to standard chemotherapy.

The study, led by American researchers and presented at the annual meeting of the American Society of Clinical Oncology in Chicago, included about 500 patients from North America, Europe, and Asia. Most participants had specific mutations in the KRAS gene, which is linked to the growth of pancreatic tumors.

Findings showed that patients who received daraxxonrasib had a median survival of around 13 months. This compares to only six months for those treated with conventional chemotherapy.

Anna Jewell, Director of Services, Research and Innovation at Pancreatic Cancer UK, described the results as “one of the most exciting advances in pancreatic cancer research in years.” She noted that extending patients’ lives gives them precious extra time with family and loved ones.

The new drug targets mutations in the KRAS gene, found in more than 90 percent of pancreatic cancer cases. It works by blocking signals that drive cancer cell growth and spread. The study also indicated that 43.6 percent of patients experienced severe side effects from the pill, which is taken once daily. In the chemotherapy group, that rate was higher, at 57.5 percent.

Experts say these results are an important step toward developing targeted therapies that address the genetic mutations driving cancer. Further research is underway to assess the long-term effectiveness of the drug and whether it can be included in future treatment protocols.

Pancreatic cancer is one of the most deadly and difficult-to-treat cancers, often diagnosed at a late stage due to subtle early symptoms. More than half of patients die within the first three months of diagnosis. Key symptoms include jaundice, itchy skin, changes in urine and stool color, unexplained weight loss, persistent fatigue, and fever.

Follow on Google News Follow on Facebook Follow on X (Twitter)
Share. Facebook Twitter Pinterest LinkedIn Email Reddit Telegram WhatsApp Copy Link
Previous ArticleNational Committee to Address the Conditions of Displaced Residents of Airport Road Buildings Holds First Meeting in Tripoli
Next Article The Supreme Committee for Youth Summer 2026 Holds Its First Meeting and Reviews the Activities Plan in Tripoli

Keep Reading

Center for Disease Control Announces State of Alert: No Ebola Cases in Libya, Warnings Issued for Travelers as Outbreak Spreads

Libyan Media Foundation Awareness Seminar Stresses Importance of Early Detection of Breast Cancer

Parliamentary Health Committee Reviews Performance of Clinics Contracted with Health Insurance Fund

Benghazi Eye Hospital Performs More Than 15 Free Surgeries to Treat Glaucoma

National Program for Early Cancer Detection Records 5 Cases in Benghazi in Two Months

Ministry of Health continues implementation of the “Health Visitor” program in Tigrhay

Follow us on Twitter

The Libya Update Verified account Follow

Stay ahead of the curve with The #Libya Update - your go-to source for news and insights on Libyan politics, business, culture, and more. #LibyaNews

TheLibyaUpdate
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
10h

MP Souad Al-Shalli Selected as Jury Member for the 2026 "Inspiring Woman" Award in Libya

Reply on Twitter 2122097029333565867 Retweet on Twitter 2122097029333565867 Like on Twitter 2122097029333565867 Twitter 2122097029333565867
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
12h

Al-Brega: Gas carriers Derna and Al-Tahadi boost supplies as congestion begins to ease

Reply on Twitter 2122062464292728945 Retweet on Twitter 2122062464292728945 Like on Twitter 2122062464292728945 Twitter 2122062464292728945
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
12h

Health Ministry announces death of girl from poisonous wild mushroom poisoning in Al-Bayda

Reply on Twitter 2122061984200012149 Retweet on Twitter 2122061984200012149 Like on Twitter 2122061984200012149 Twitter 2122061984200012149
libya update
Facebook X (Twitter) RSS

News

  • National News
  • The Maghreb News
  • Middle East News
  • Business News
  • Sports News

Company

  • Information
  • Ethics Policy
  • Corrections Policy
  • Fact-Checking Policy
  • GDPR Policy

Categories

  • Editors’ Picks
  • Opinion
  • Health & Lifestyle
  • Videos
  • Infographics

Subscribe to Updates




    © 2026 All copyrights reserved. The Libya Update.
    • About Us
    • Privacy Policy
    • Advertising

    Type above and press Enter to search. Press Esc to cancel.